All54 Filings49 News0 Corp actions5 Official filings · newest first AARTIPHARM exchange filings, corporate actions and results 2 Sep 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 BSE filing · raw filing ↗ 31 Aug 2026
⚑ Filing
Resignation of Director/KMP/SMP NSE filing · raw filing ↗ 31 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management BSE filing · raw filing ↗ 30 Aug 2026
⚑ Filing
Copy of Newspaper Publication NSE filing · raw filing ↗ 30 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication BSE filing · raw filing ↗ 29 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Business Responsibility and Sustainability Reporting (BRSR) BSE filing · raw filing ↗ 29 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Notice Of 7Th Annual General Meeting Of The Company BSE filing · raw filing ↗ 29 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Reg. 34 (1) Annual Report. BSE filing · raw filing ↗ 18 Aug 2026
⚑ Filing
Copy of Newspaper Publication NSE filing · raw filing ↗ 18 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication BSE filing · raw filing ↗ 17 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Record Date For Dividend For FY 2025-26 BSE filing · raw filing ↗ 17 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 17 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript BSE filing · raw filing ↗ 10 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 10 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome BSE filing · raw filing ↗ 10 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE filing · raw filing ↗ 9 Aug 2026
⚑ Filing
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication BSE filing · raw filing ↗ 9 Aug 2026
⚑ Filing
Copy of Newspaper Publication NSE filing · raw filing ↗ 7 Aug 2026
⚑ Filing
Q1 FY27 results filed — revenue ₹536 Cr (+38.7% YoY), PAT ₹76 Cr (+53.8% YoY) NSE filing · raw filing ↗ 3 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 7 Jul 2026
⚑ Filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 NSE filing · raw filing ↗ 22 Jun 2026
⚑ Filing
Disclosure under SEBI Takeover Regulations NSE filing · raw filing ↗ 12 Jun 2026
⚑ Filing
Disclosure under SEBI Takeover Regulations NSE filing · raw filing ↗ 1 Jun 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 27 May 2026
⚑ Filing
Copy of Newspaper Publication NSE filing · raw filing ↗ 26 May 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 25 May 2026
⚑ Filing
Q4 FY26 results filed — revenue ₹583 Cr (+3.3% YoY), PAT ₹61 Cr (−30.8% YoY) NSE filing · raw filing ↗ 20 May 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ 20 May 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call Updates NSE filing · raw filing ↗ Ex-date 16 Feb 2026
⚑ Corp action
Dividend — ₹1.50 per share NSE filing · record 16 Feb 2026 Ex-date 15 Sep 2025
⚑ Corp action
Dividend — ₹2.50 per share NSE filing · record 15 Sep 2025 Ex-date 14 Feb 2025
⚑ Corp action
Dividend — ₹2.50 per share NSE filing · record 14 Feb 2025 Ex-date 31 Jul 2024
⚑ Corp action
Dividend — ₹1.00 per share NSE filing · record 31 Jul 2024 Ex-date 16 Feb 2024
⚑ Corp action
Dividend — ₹2.00 per share NSE filing · record 19 Feb 2024 NOT BUILT YET Per-item summaries & sentiment — not built yet One-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
